Accessibility StatementSkip Navigation NEWTOWN, Pa., Nov. 17, 2025 /PRNewswire/ --Â Edelson Lechtzin LLP, a national class action law firm, is investigating potential violations of the federal securities laws involving Netflix, Inc. (NASDAQ: NFLX), resulting from allegations of providing potentially misleading business information to the investing public. If you have non-public information that could assist in the Netflix Investigation or if you are a Netflix investor who suffered a loss and would like to l ...

Company Overview - Varonis Systems, Inc. is a data security firm that specializes in protecting and managing sensitive data across both on-premises and cloud environments through threat detection, access control, and compliance automation [3]. Allegations and Financial Performance - On October 28, 2025, Varonis Systems reported Q3 results that fell short of expectations, with term license subscriptions, which account for 15.4% of total revenues, decreasing by 63.9% to $24.8 million [4]. - Maintenance and services, representing 9.1% of total revenues, declined by 49.1% to $10.9 million [4]. - The company revised its annual recurring revenue (ARR) forecast downward, attributing this to weak on-premises subscriptions and sales issues [4]. - Following the announcement of these results, Varonis stock experienced a significant drop of 48.67%, closing at $32.34 per share on October 29, 2025 [4]. Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Varonis Systems, stemming from allegations of providing misleading business information to the investing public [1][4].

Core Viewpoint - Jefferies Financial Group Inc. and its trade finance arm, Point Bonita Capital, are under investigation for potential violations of federal securities laws following significant exposure to First Brands Group, which recently filed for bankruptcy [1][3][5]. Group 1: Company Overview - Jefferies Financial Group Inc. operates as an investment banking and capital markets firm, with Point Bonita Capital serving as its trade finance division [3]. - The firm had approximately $715 million in exposure to First Brands' receivables, accounting for about 25% of Point Bonita's trade finance portfolio [4]. Group 2: Financial Impact - Following the announcement of the exposure to First Brands, Jefferies' stock price dropped by $4.66 per share, or approximately 8%, from $59.10 on October 7, 2025, to $54.44 on October 8, 2025 [4]. Group 3: Legal Investigation - Bleichmar Fonti & Auld LLP is investigating whether Jefferies and Point Bonita made materially false and misleading statements to investors regarding their exposure to First Brands [5]. - Investors are reportedly seeking redemptions from Point Bonita due to the financial fallout from First Brands' bankruptcy [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against WPP plc due to allegations of violations of federal securities laws, particularly concerning misleading statements about the company's expected revenue for fiscal year 2025 [3][4]. Group 1: Allegations and Company Performance - The complaint alleges that WPP and its executives made false and misleading statements regarding the company's media division, claiming confidence in revitalization efforts while concealing significant market share losses to competitors [3]. - WPP's trading update on July 9, 2025, revealed a deterioration in performance attributed to macroeconomic uncertainties and weaker new business, which was partly due to ongoing restructuring efforts [4]. - Following the trading update, WPP's stock price fell from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking an 18.1% decline in just one day [5]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased WPP securities between February 27, 2025, and July 8, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights, with a deadline of December 8, 2025, to seek the role of lead plaintiff in the class action [1][6]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [6]. - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding WPP's conduct [7].

Share Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK--(BUSINESS WIRE)--Faruq ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In WPP To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $10,000 in WPP between February 27, 2025 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) ...

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Fiserv, Inc. regarding possible violations of federal securities laws and other unlawful business practices affecting stockholders [2][4]. Investigation Details - The investigation is focused on whether Fiserv has engaged in practices that may have harmed investors, particularly following recent financial disclosures [2][8]. Recent Developments - On October 29, 2025, Fiserv reported a sequential decline in Q3 2025 adjusted revenue and reduced its organic revenue growth expectations to 3.5%-4% [8]. - The company also lowered its EPS outlook to $8.50-$8.60 and announced significant leadership changes, including the departure of its CFO and a shake-up of the board of directors [8]. - Following these announcements, Fiserv's stock price dropped over $59 in intraday trading, resulting in a loss of $32 billion in shareholder value in one day [8]. Leadership Changes - Michael Lyons was appointed as the new CEO, and Doyle Simmons became the non-executive Chairman after the previous CEO, Frank Bisignano, was confirmed as Commissioner of the Social Security Administration [8]. - Lyons indicated that a thorough analysis of the company's operations led to the reassessment of previous growth assumptions and the identification of short-term driven initiatives that were not sustainable [8]. Contact Information - Investors who have suffered losses and wish to discuss their legal rights can contact Bragar Eagel & Squire, P.C. directly [4][9].

Core Insights - Faruqi & Faruqi, LLP is investigating potential claims against aTyr Pharma, Inc. due to allegations of violations of federal securities laws related to misleading statements about the drug Efzofitimod [2][5] - The firm is encouraging investors who suffered losses exceeding $50,000 between January 16, 2025, and September 12, 2025, to discuss their legal options [1][2] Company Overview - aTyr Pharma, Inc. is facing a federal securities class action with a deadline for lead plaintiff applications set for December 8, 2025 [2] - The company’s stock experienced a significant decline of 83.25%, dropping from $6.03 on September 12, 2025, to $1.01 on September 15, 2025, following the release of disappointing clinical trial results for Efzofitimod [6] Legal Allegations - The complaint alleges that aTyr and its executives made false and misleading statements regarding the efficacy of Efzofitimod, particularly its ability to allow patients to taper off steroid usage [5] - In the EFZO-FIT study, the drug did not demonstrate a significant reduction in mean daily oral corticosteroid dose compared to placebo, with only 52.6% of patients achieving complete steroid withdrawal [6]

Core Insights - CarMax, Inc. reported significant declines in revenue and profit for the second quarter of fiscal year 2026, with a revenue decrease of 6.0%, a 7.2% drop in total retail used vehicle revenues, and a 5.6% decline in total gross profit [2] - Following the financial results announcement, CarMax's stock price fell by $11.45 per share, approximately 20%, closing at $45.60 on September 25, 2025, down from $57.05 the previous day [2] Company Investigation - Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws on behalf of CarMax investors [1][3] - The law firm has a history of prosecuting class actions related to securities fraud and has recovered billions for investors [3]

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Brunello Cucinelli S.p.A. for possible violations of federal securities laws and unlawful business practices [2][3]. Investigation Details - The investigation is focused on whether Brunello Cucinelli has engaged in unlawful business practices, particularly concerning its operations in Russia following the invasion of Ukraine [2][7]. - A report by Morpheus Research claims that Brunello Cucinelli has misrepresented its business activities in Russia, which has led to significant stock price declines [7]. Stockholder Rights - Investors who purchased Brunello Cucinelli shares and suffered losses are encouraged to contact Bragar Eagel & Squire for legal options [1][4]. - The law firm offers assistance without any cost or obligation to the investors [4].